Sector footprint
$3.5M in exports
Reported chemicals exports in 2024 across 22 qualifying HS6 products.
Sector export playbook ยท HS 28-38
Explore Sri Lanka's HS 28-38 product portfolio, buyer markets, growth signals, and diversification opportunities. Use this guide to prioritize research, not to treat calculated indicators as guaranteed sales.
Chemicals capability
Compare exporter scale with product breadth, buyer demand, growth, and destination reach. A large sector does not remove the need for product, compliance, pricing, and buyer validation.
Sector footprint
Reported chemicals exports in 2024 across 22 qualifying HS6 products.
Global demand
The sector's reported buyer import base provides context for product and market prioritization.
How to use the guide
Start with products that combine demand and exporter capability, then validate standards, route economics, buyers, and competition.
Product portfolio
Each HS6 product is ranked by calculated opportunity and shown with reported market size, exporter exports, growth, and destination reach.
| Product | Global size | Your exports | Opportunity | CAGR | Markets | Share |
|---|---|---|---|---|---|---|
| HS 300490Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale | $301.0B | $546.5K | $113.7B | +11.1% | 20 | +0.0% |
| HS 382499Chemical products, mixtures and preparations: n.e.c. heading 3824 | $29.3B | $382.9K | $20.1B | +16.7% | 11 | +0.0% |
| HS 300220Vaccines: for human medicine | $10.4B | $168.9 | $10.8B | -21.8% | 3 | +0.0% |
| HS 330210Odoriferous substances and mixtures: of a kind used in the food or drink industries | $7.9B | $2.1K | $10.7B | -2.1% | 3 | +0.0% |
| HS 330499Cosmetic and toilet preparations: n.e.c. in heading no. 3304, for the care of the skin (excluding medicaments, including sunscreen or sun tan preparations) | $18.2B | $2.5M | $8.0B | +25.8% | 4 | +0.0% |
| HS 300439Medicaments: containing hormones (but not insulin), adrenal cortex hormones or antibiotics, for therapeutic or prophylactic uses, packaged for retail sale | $8.2B | $1.2K | $6.1B | -11.3% | 4 | +0.0% |
| HS 382200Reagents: diagnostic or laboratory reagents on a backing and prepared diagnostic or laboratory reagents whether or not on a backing, other than those of heading no. 3002 or 3006: certified reference material | $12.4B | $8.2K | $4.6B | +9.9% | 3 | +0.0% |
| HS 330300Perfumes and toilet waters | $7.0B | $6.3K | $3.6B | +12.4% | 2 | +0.0% |
| HS 300212Blood, human or animal, antisera, other blood fractions and immunological products: antisera and other blood fractions | $5.5B | $395.4 | $3.2B | +33.7% | 1 | +0.0% |
| HS 300215Blood, human or animal, antisera, other blood fractions and immunological products: immunological products, put up in measured doses or in forms or packings for retail sale | $8.0B | $18.6 | $2.9B | -5.4% | 1 | +0.0% |
| HS 300390Medicaments: (not containing antibiotics, hormones, alkaloids or their derivatives), for therapeutic or prophylactic uses, (not packaged for retail sale) | $3.8B | $6.9K | $2.2B | +10.9% | 2 | +0.0% |
| HS 370790Photographic goods: chemical preparations other than sensitised emulsions, put up in measured portions or put up for retail sale in a form ready for use | $2.2B | $361.0 | $1.8B | -2.8% | 1 | +0.0% |
| HS 381512Catalysts, supported: reaction initiators, reaction accelerators and catalytic preparations, with precious metal or precious metal compounds as the active substance, n.e.c. or included | $1.4B | $51.3 | $1.7B | -4.4% | 1 | +0.0% |
| HS 284690Compounds, inorganic or organic (excluding cerium), of rare-earth metals, of yttrium, scandium or of mixtures of these metals | $1.4B | $107.7 | $1.5B | +3.7% | 1 | +0.0% |
| HS 340220Washing and cleaning preparations: surface-active, whether or not containing soap (excluding those of heading no. 3401), put up for retail sale | $1.2B | $111.2 | $1.4B | -3.2% | 1 | +0.0% |
| HS 321590Ink: writing, drawing and other inks, n.e.c. in heading no. 3215, whether or not concentrated or solid | $674.3M | $0.7 | $1.1B | -29.2% | 1 | +0.0% |
| HS 300290Toxins, cultures of micro-organisms (excluding yeasts) and similar products | $2.7B | $1.3 | $1.0B | +5.6% | 1 | +0.0% |
| HS 310210Fertilizers, mineral or chemical: nitrogenous, urea, whether or not in aqueous solution | $2.0B | $7.8K | $1.0B | -0.4% | 1 | +0.0% |
| HS 382319Industrial monocarboxylic fatty acids: acid oils from refining: (other than stearic acid, oleic acid or tall oil fatty acids) | $669.2M | $1.9K | $1.0B | +1.8% | 1 | +0.0% |
| HS 320611Colouring matter: pigments and preparations based on titanium dioxide, containing 80% or more by weight of titanium dioxide calculated on the dry matter | $1.1B | $2.2K | $997.2M | -10.0% | 1 | +0.0% |
| HS 294190Antibiotics: n.e.c. in heading no. 2941 | $883.6M | $25.0K | $990.0M | +4.9% | 1 | +0.0% |
| HS 293499Nucleic acids and their salts, other heterocyclic compounds, n.e.c. in heading number 2934 | $895.5M | $0.5 | $959.0M | -57.3% | 1 | +0.0% |
Best markets
Markets are ranked by calculated opportunity across the qualifying products in this sector view.
USA
8 products represented in the sector.
$38.1B$110.0B reported buyer importsCHE
3 products represented in the sector.
$33.9B$54.6B reported buyer importsBEL
3 products represented in the sector.
$16.1B$27.1B reported buyer importsCHN
5 products represented in the sector.
$14.2B$33.3B reported buyer importsGBR
5 products represented in the sector.
$10.8B$21.8B reported buyer importsSVN
1 products represented in the sector.
$9.7B$7.6B reported buyer importsDEU
5 products represented in the sector.
$9.7B$37.6B reported buyer importsCAN
4 products represented in the sector.
$7.5B$11.6B reported buyer importsMEX
3 products represented in the sector.
$7.3B$5.7B reported buyer importsFRA
4 products represented in the sector.
$6.6B$17.9B reported buyer importsNLD
1 products represented in the sector.
$5.3B$10.5B reported buyer importsESP
1 products represented in the sector.
$5.2B$11.9B reported buyer importsGrowth stars
Average product-level CAGR is a screening signal. Confirm the latest trend, base effects, buyer quality, and commercial feasibility before acting.
| Product | Average CAGR | Opportunity | Markets |
|---|---|---|---|
| HS 300212Blood, human or animal, antisera, other blood fractions and immunological products: antisera and other blood fractions | +33.7% | $3.2B | 1 |
| HS 330499Cosmetic and toilet preparations: n.e.c. in heading no. 3304, for the care of the skin (excluding medicaments, including sunscreen or sun tan preparations) | +25.8% | $8.0B | 4 |
| HS 382499Chemical products, mixtures and preparations: n.e.c. heading 3824 | +16.7% | $20.1B | 11 |
| HS 330300Perfumes and toilet waters | +12.4% | $3.6B | 2 |
| HS 300490Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale | +11.1% | $113.7B | 20 |
| HS 300390Medicaments: (not containing antibiotics, hormones, alkaloids or their derivatives), for therapeutic or prophylactic uses, (not packaged for retail sale) | +10.9% | $2.2B | 2 |
| HS 382200Reagents: diagnostic or laboratory reagents on a backing and prepared diagnostic or laboratory reagents whether or not on a backing, other than those of heading no. 3002 or 3006: certified reference material | +9.9% | $4.6B | 3 |
| HS 300290Toxins, cultures of micro-organisms (excluding yeasts) and similar products | +5.6% | $1.0B | 1 |
| HS 294190Antibiotics: n.e.c. in heading no. 2941 | +4.9% | $990.0M | 1 |
| HS 284690Compounds, inorganic or organic (excluding cerium), of rare-earth metals, of yttrium, scandium or of mixtures of these metals | +3.7% | $1.5B | 1 |
Diversification opportunities
Destination count is a simple breadth indicator. It does not measure destination concentration or guarantee resilience.
HS 300490
HS 382499
HS 330499
HS 300439
HS 300220
HS 330210
HS 382200
HS 330300
Frequently asked questions
Practical guidance for interpreting sector scale, growth, product breadth, and buyer markets.
Compare sector exports, product breadth, buyer markets, growth, and global demand. These signals identify research priorities rather than guarantee market access.
Products with higher average reported growth in the screened rows. Validate the time period, base effects, buyer demand, and current exporter position.
Products reaching more buyer markets in the screened data. Destination breadth is useful context but does not replace concentration, route, or buyer analysis.
Data source
OECD (2025), Balanced international merchandise trade statistics (BIMTS) - HS2017-6D, OECD Data Explorer (accessed on 2026-08-30). OECD BIMTS is the primary trade series for this view. Supporting bilateral trade context uses CEPII BACI bilateral trade flows (202601) under Etalab 2.0 Open Licence. Yugalinks presents derived views of reported observations and calculated indicators. Data terms: OECD Terms & Conditions.